Corient Capital Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$923K Buy
13,966
+2,318
+20% +$153K 0.07% 230
2022
Q2
$770K Sell
11,648
-25,417
-69% -$1.68M 0.06% 262
2022
Q1
$2.46M Sell
37,065
-2,103
-5% -$140K 0.16% 133
2021
Q4
$2.28M Sell
39,168
-7,398
-16% -$431K 0.15% 138
2021
Q3
$2.8M Buy
46,566
+3,578
+8% +$215K 0.2% 108
2021
Q2
$2.58M Sell
42,988
-37
-0.1% -$2.22K 0.19% 116
2021
Q1
$2.14M Sell
43,025
-20,452
-32% -$1.02M 0.18% 115
2020
Q4
$3.17M Buy
63,477
+6,543
+11% +$327K 0.32% 77
2020
Q3
$3.12M Sell
56,934
-2,154
-4% -$118K 0.36% 67
2020
Q2
$3.13M Buy
59,088
+5,148
+10% +$272K 0.38% 64
2020
Q1
$2.41M Buy
53,940
+1,702
+3% +$76K 0.38% 66
2019
Q4
$2.6M Buy
52,238
+770
+1% +$38.4K 0.33% 70
2019
Q3
$2.29M Buy
51,468
+6,837
+15% +$305K 0.32% 70
2019
Q2
$1.84M Buy
44,631
+2,342
+6% +$96.7K 0.28% 86
2019
Q1
$1.71M Sell
42,289
-3,583
-8% -$145K 0.28% 104
2018
Q4
$1.74M Sell
45,872
-41,037
-47% -$1.56M 0.31% 94
2018
Q3
$3.44M Hold
86,909
0.57% 37
2018
Q2
$3.05M Sell
86,909
-49,826
-36% -$1.75M 0.53% 42
2018
Q1
$4.78M Sell
136,735
-20,700
-13% -$724K 0.88% 18
2017
Q4
$5.46M Buy
157,435
+6,441
+4% +$224K 0.93% 20
2017
Q3
$5.12M Sell
150,994
-14,430
-9% -$489K 0.97% 19
2017
Q2
$5.64M Sell
165,424
-7,171
-4% -$244K 0.86% 27
2017
Q1
$5.38M Buy
172,595
+150,796
+692% +$4.7M 0.84% 29
2016
Q4
$596K Sell
21,799
-111,352
-84% -$3.04M 0.11% 179
2016
Q3
$4.38M Buy
+133,151
New +$4.38M 0.81% 29